ParaEM: Antigen-aware sequence-based paratope prediction with Expectation-Maximization.
MOTIVATION: Accurate identification of antibody paratopes-the residues contacting the antigen-is vital for understanding antibody-antigen recognition, antibody engineering, and vaccine design. However, structure-based predictors require antibody structural inputs, which are often obtained from experimentally determined antibody-antigen complexes in benchmark settings but are generally unavailable for new sequences. Conversely, sequence-based predictors scale efficiently but remain largely antigen-agnostic, limiting their use of pair-specific antigen context. RESULTS: We introduce ParaEM, an antigen-aware sequence-based paratope predictor that operates directly on antibody and antigen sequences. ParaEM leverages pretrained ESM3 embeddings to encode both sequences, augmenting antibody residues with trainable, CDR-informed embeddings to introduce a biologically informed inductive bias. It models interactions via a residue-level compatibility scorer that defines latent antigen-anchor distributions. During training, a generalized Expectation-Maximization (EM) framework alternates between estimating label-conditioned posterior responsibilities (E-step) and performing gradient-based parameter updates (M-step). Evaluated across three established benchmarks, ParaEM outperforms existing sequence-based baselines in AUC-PR and achieves performance competitive with structure-based predictors without requiring explicit 3D structural inputs. Ablation studies show consistent improvements from generalized EM optimization and an additional gain from CDR-informed embeddings. Antibody-side and antigen-information controls further show that antibody sequence carries substantial predictive signal, while the matching antigen provides additional predictive information. Together, these results support ParaEM as a scalable framework for incorporating matching-antigen context into sequence-based paratope prediction. AVAILABILITY AND IMPLEMENTATION: ParaEM is available at https://github.com/kimtaegyuu/ParaEM. An archival snapshot of the software corresponding to this study is available on Zenodo at DOI: 10.5281/zenodo.22157100. SUPPLEMENTARY INFORMATION: Supplementary data are available.
Authors
- Inuk Jung (ORCID: https://orcid.org/0000-0003-0675-4244)
- 조창윤
- 김태규
- Sun Kim
Institutions
- Seoul National University (KR)
- Kyungpook National University (KR)
- AIGENDRUG Co., Ltd. (South Korea) (KR)
Publication Details
- Journal
- PubMed
- Published
- 2026-10-05
- DOI
- https://doi.org/10.1093/bioinformatics/btag739
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00